INNOVATIVE MEDICINES INITIATIVE IN THE ANDALUSIAN REGION. ON THE FRONTIER OF ADVANCED CLINICAL PHARMACOLOGY

被引：0
|
作者：
Lucena, M. I. [1 ,2 ]
Hernandez, C. [3 ]
机构：
[1] Univ Malaga, Sch Med, Univ Hosp Virgen Victoria, Clin Pharmacol Serv, Malaga, Spain
[2] CIBERehd, Barcelona, Spain
[3] Spanish Agcy Med & Med Devices, Madrid, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2011年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：15 / 15
页数：1
相关论文
共 4 条
  • [1] THE ANDALUSIAN INITIATIVE FOR ADVANCED THERAPIES: A PIONEER MODEL TO FOSTER THE INCORPORATION OF THESE INNOVATIVE THERAPIES INTO THE CLINICAL PRACTICE
    Laricchia-Robbio, L.
    Rico, L.
    Oruezabal, R. I.
    del Carmen, C.
    Carmona, G.
    Mata, R.
    Cuende, N.
    [J]. CYTOTHERAPY, 2015, 17 (06) : S80 - S80
  • [2] The Organizational Model to Facilitate NonCommercial Clinical Translation in Advanced Therapies Developed by the Andalusian Initiative for Advanced Therapies
    Cuende, Natividad
    [J]. HUMAN GENE THERAPY, 2009, 20 (09) : 1029 - 1029
  • [3] Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'
    Galluzzi, S.
    Marizzoni, M.
    Babiloni, C.
    Albani, D.
    Antelmi, L.
    Bagnoli, C.
    Bartres-Faz, D.
    Cordone, S.
    Didic, M.
    Farotti, L.
    Fiedler, U.
    Forloni, G.
    Girtler, N.
    Hensch, T.
    Jovicich, J.
    Leeuwis, A.
    Marra, C.
    Molinuevo, J. L.
    Nobili, F.
    Pariente, J.
    Parnetti, L.
    Payoux, P.
    Del Percio, C.
    Ranjeva, J. -P.
    Rolandi, E.
    Rossini, P. M.
    Schoenknecht, P.
    Soricelli, A.
    Tsolaki, M.
    Visser, P. J.
    Wiltfang, J.
    Richardson, J. C.
    Bordet, R.
    Blin, O.
    Frisoni, G. B.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2016, 279 (06) : 576 - 591
  • [4] Setting International Standards in Analyzing Patient- Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI) stakeholder views, objectives, and procedures
    Pe, Madeline
    Alanya, Ahu
    Falk, Ragnhild Sorum
    Amdal, Cecilie Delphin
    Bjordal, Kristin
    Chang, Jane
    Cislo, Paul
    Coens, Corneel
    Dirven, Linda
    Speck, Rebecca M.
    Fitzgerald, Kristina
    Galinsky, Jayne
    Giesinger, Johannes M.
    Holzner, Bernhard
    Le Cessie, Saskia
    O'Connor, Daniel
    Oliver, Kathy
    Pawar, Vivek
    Quinten, Chantal
    Schlichting, Michael
    Ren, Jinma
    Roychoudhury, Satrajit
    Taphoorn, Martin J. B.
    Velikova, Galina
    Wintner, Lisa M.
    Griebsch, Ingolf
    Bottomley, Andrew
    [J]. LANCET ONCOLOGY, 2023, 24 (06): : E270 - E283
1